Evidence map›Paper›PMID 41440893›Full record

ReviewMarine drugs2025

A Journey into the Blue: Current Knowledge and Emerging Insights into Marine-Derived Peptaibols.

Claudia Finamore, Carmen Festa, Mattia Cammarota, Simona De Marino, Maria Valeria D'Auria

Abstract readReview
In one paragraph

Review in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Claudia FinamoreDepartment of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0003-3064-0415
Carmen FestaDepartment of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0001-8879-4332
Mattia CammarotaDepartment of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0009-0009-8085-2118
Simona De MarinoDepartment of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0002-0300-5048
Maria Valeria D'AuriaDepartment of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0003-3450-7304

Funding

Italian Ministry of University and Research 2022MPTT35
6 · The paper itself

Abstract

Peptaibols represent a large family of membrane-active, linear fungal peptides, with variable lengths from 5 to 21 α-amino acid residues. As products of nonribosomal peptide synthetase (NRPS) biosynthetic machinery, they encompass several non-proteinogenic amino acids, particularly the Cα-tetrasubstituted residues, such as α-aminoisobutyric acid (Aib) and its homologue isovaline (Iva). Further distinctive features include an N-acyl terminus, such as an acetyl group, and a C-terminus containing an amino alcohol residue (such as phenylalaninol, leucinol, and valinol, among others), which neutralize charges at both termini and confer them a hydrophobic nature. Peptaibols not only represent the most abundant class among nonribosomal peptides, but they have also attracted continuous scientific interest due to their diverse pharmacological properties, including antimicrobial, cytotoxic, antifungal, and antiviral activities. In this review, we present for the first time the recently explored chemodiversity of fungal peptaibiotics derived from marine sources, with a particular focus on peptaibols. We discuss their distinctive structural features, chemical characterization, biosynthetic pathways, and biological activity profiles, with the aim of supporting ongoing research toward their development as potential pharmaceutical agents.

Indexed as

Aquatic OrganismsPeptaibolsAnimalsFungiHumansPeptaibolsbioactivitybiosynthesismarine fungipeptaibolspeptidesTrichoderma

Identifiers

PMID41440893
PMCPMC12734927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.